Screening sigmoidoscopy and colonoscopy for reducing colorectal cancer mortality in asymptomatic persons

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 9, 2013, Pages

  Phillips, Jessica ^a   Ridd, Catherine ^a   Thomas, Kathryn ^b  

^a ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; FOLLOW UP; HUMAN; INTENTION TO TREAT ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT; SIGMOIDOSCOPY; SYSTEMATIC REVIEW;

EID: 85019178657     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005201.pub2     Document Type: Article

References (32)

1. Atkin W, Edwards R, Kralj-Hans I, Wooldrage K, Hart A, Northover J, et al.Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375(9726):1624-33. [DOI: 10.1016/S0140-6736(10)60551-X]
2. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach D, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Annals of Internal Medicine 2009;150(1):1-8. [DOI: 10.7326/0003-4819-150-1-200901060-00306]
3. BCSP Quality Assurance Endoscopy Group. Quality assurance guidelines for colonoscopy. http://www.cancerscreening.nhs.uk/bowel/publications/nhsbcsp06.pdf 2011, issue 6.
4. Brenner H, Hoffmeister M, Arndt V, Stegmaier C, Altenhofen L, Haug U. Protection from right-and left-sided colorectal neoplasms after colonoscopy: population-based study. Journal of the National Cancer Institute 2010;102(2):89-95. [DOI: 10.1093/jnci/djp436]
5. Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M, The Italian Multicentre Study Group. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 2001;48(6):812-5. [DOI: 10.1136/gut.48.6.812]
6. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. http://globocan.iarc.fr/factsheets/cancers/colorectal.asp, Accessed 1/1/12 2010.
7. Gupta S, Balasubramanian BA, Fu T, Genta RM, Rockley DC, Lash R. Polyps with advanced neoplasia are smaller in the right than in the left colon: implications for colorectal cancer screening. Clinical Gastroenterlology and Hepatology 2012;10(12):1395-401. [DOI: 10.1016/j.cgh.2012.07.004]
8. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al.Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348(9040):1472-7.
9. Hewitson P, Glasziou PP, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD001216.pub2]
10. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions 5.1.0. The Cochrane Collaboration March 2011. [ Available from www.cochrane-handbook.org]. The Cochrane Collaboration.
11. Hoff G, Skovlund E, Bretthauer M. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ 2009;338:b1846. [DOI: 10.1136/bmj.b1846]
12. International Cancer Screening Network. Inventory of colorectal cancer screening activities in ICSN countries, May 2008. http://appliedresearch.cancer.gov/icsn/colorectal/screening.html, Accessed 1/12/12.
13. Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348(9040):1467-71.
14. Lemon SC, Zapka JG, Estabrook B, Erban S, Luckmann R. Screening for colorectal cancer on the front line. American Journal of Gastroenterology 2003;98(4):915-23.
15. Lieberman D, Weiss D, Bond J, Ahnen D, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. New England Journal of Medicine 2000;343(3):162-8. [DOI: 10.1056/NEJM200007203430301]
16. Lindholm E, Brevinge H, Haglind E. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. British Journal of Surgery 2008;95(8):1029-36.
17. Logan R, Patnick J, Nickerson C, Coleman L, Rutter M, von Wagner C. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut 2012;61(10):1439-46. [DOI: 10.1136/gutjnl-2011-300843]
18. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al.Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. New England Journal of Medicine 1993;328(19):1365-71.
19. Mulder SA, van Soest EM, Dieleman JP, van Rossum LG, Ouwendijk RJ, van Leerdam ME, et al.Exposure to colorectal examinations before a colorectal cancer diagnosis: a case-control study. European Journal of Gastroenterology and Hepatology 2010;22(4):437-43. [DOI: 10.1097/MEG.0b013e328333fc6a]
20. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Archives of Internal Medicine 1995;155(16):1741-8.
21. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. Journal of the National Cancer Institute 1992;84(20):1572-5.
22. Niv Y, Sperber AD. Sensitivity, specificity, and predictive value of fecal occult blood testing (Hemoccult II) for colorectal neoplasia in symptomatic patients: a prospective study. American Journal of Gastroenterology 1995;90(11):1974-7.
23. Nnoaham K, Frater A, Roderick P, Moon G, Halloran S. Do geodemographic typologies explain variations in uptake in colorectal cancer screening? An assessment using routine screening data in the south of England. Journal of Public Health 2010;32(4):572-81. [DOI: 10.1093/pubmed/fdq025]
24. Podolsky DK. Going the distance--the case for true colorectal-cancer screening. New England Journal of Medicine 2000;343(3):207-8.
25. Rabeneck L, Paszat LF. A population-based estimate of the extent of colorectal cancer screening in Ontario. American Journal of Gastroenterology 2004;99(6):1141-4.
26. Rondagh EJ, Bouwens MW, Riedl RG, Winkens B, de Ridder R, Kaltenbach T, et al.Endoscopic appearance of proximal colorectal neoplasms and potential implications for colonoscopy in cancer prevention. Gastrointestinal Endoscopy 2012;75(6):1218-25. [DOI: 10.1016/j.gie.2012.02.010]
27. Segnan N, Armaroli P, Bonelli L, Risio M, Sciallero S, Zappa M, et al.Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian randomized controlled trial -SCORE. Journal of the National Cancer Institute 2011;103(17):1310-22. [DOI: 10.1093/jnci/djr284]
28. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. New England Journal of Medicine 1992;326(10):653-7.
29. Singh H, Nugent Z, Demers AA, Kliewer EV, Mahmud SM, Bernstein CN. The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology 2010;139(4):1128-37. [DOI: 10.1053/j.gastro.2010.06.052]
30. Weissfeld J, Schoen R, Pinsky P, Bresalier R, Doria-Rose V, Laiyemo A, et al.Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination. Journal of the National Cancer Institute 2012;104(4):280-9. [DOI: 10.1093/jnci/djr549]
31. Whyte S, Chilcott J, Cooper K, Essat M, Stevens J, Wong R, et al.Re-appraisal of the options for colorectal cancer screening. http://www.cancerscreening.nhs.uk/bowel/scharr-full-report-summary-201202.pdf 2011.
32. Lin O, Roy PK, Schembre DB, Kozarek RA. Screening sigmoidoscopy and colonoscopy for reducing colorectal cancer mortality in asymtomatic persons. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD005201]